Source: ERJ Open Res 2016: 00024-2015
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jantina C. de Groot, Anneke ten Brinke, Elisabeth H.D. Bel.. “Management of the patient with eosinophilic asthma: a new era begins”. ERJ Open Res 2016: 00024-2015

Member's Comments

No comment yet.

Related content which might interest you: Severe eosinophilic asthma: a roadmap to consensus Source: Eur Respir J, 49 (5) 1700634; 10.1183/13993003.00634-2017 Year: 2017 Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme Source: Eur Respir J, 55 (6) 1902345; 10.1183/13993003.02345-2019 Year: 2020 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 International perspectives on severe asthma: Current and future challenges in patient care Source: International Congress 2016 – Asthma points to ponder Year: 2016 Not all that wheezes is asthma: A case report of diffuse tracheobronchomalacia in an adult Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Development of asthma in patients with eosinophilic bronchitis: prospective follow up study Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Real-life experience with mepolizumab in the French early access program for severe eosinophilic asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003 Infection associated phenotype of asthma: Results of a difficult asthma clinic service improvement project Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma. Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Severe asthma: approach to diagnosis and treatment Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with asthma Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Source: Eur Respir J 2014; 43: 1233-1236 Year: 2014 Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013